Skip to main content
. 2020 May 28;41(7):895–901. doi: 10.1038/s41401-020-0423-5

Fig. 3. Biologically derived nanoparticles for activation of dendritic cells (DCs).

Fig. 3

a Exosome-based dual vaccine. Tumor-derived exosomes were incubated with DCs to generate DC-derived membrane vesicles (DC-mvs), which were injected into mice. Copyright (2012) Elsevier Ltd. b Membrane-based tumor vaccine. The tumor cell membrane (antigen) and CpG (adjuvant) were codelivered to antigen-presenting cells (blue), and activated T cells (tan) killed tumor cells. Copyright (2017) John Wiley & Sons, Inc.